NCCS Starburst Thumbnail

Journey Forward recognized for extraordinary contribution with Health Impact Award

/in , ,

Journey Forward has received the Wellsphere’s Health Impact Award for its extraordinary contributions to cancer survivors. The award acknowledges that the program has increased progress in areas such as health research, understanding, empathy, inspiration, awareness, accessibility, and networking.

Journey Forward is an innovative nationwide program to promote the use of Survivorship Care Plans that will help establish a new standard of care for cancer survivors, enhance patient and physician understanding of late effects of cancer treatment and survivorship, and improve continuity and coordination of care.

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

NCCS adds care planning to Teamwork resourceFacebookProfile3FacebookProfile3NCCS comments on FDA’s draft guidance for in vitro companion diagnostic...